Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-01-17FDA Approved: NATEGLINIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for NATEGLINIDE by Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2023-01-13Clinical Trial Update: Adaptation of a Digital Weight Loss Intervention Promoting Self-regulation for Use in Type 2 Diabetes [NA]
A completed clinical trial adapting a digital weight loss intervention to promote self-regulation for use in type 2 diabetes, with results p…
-
FDA approval · 2023-01-12FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for OZEMPIC (oral semaglutide) submitted by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: MSC and MC in Type 2 Diabetes Mellitus [Phase 1, Phase 2]
Phase 1/2 clinical trial update for MSC and MC in Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2023-01-11Clinical Trial Update: Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study [Phase 4]
Phase 4 clinical trial investigating insulin resistance in individuals with mild cognitive impairment has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-01-10FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Micro Labs Limited)
FDA approved Micro Labs Limited's metformin hydrochloride product under an Original Application (ANDA 212448) for use as a generic treatment…
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo) [Phase 3]
Phase 3 trial update for tirzepatide (LY3298176) in adults with type 2 diabetes on metformin with or without sulfonylurea (SURPASS-AP-Combo)…
-
CLINICAL_TRIALS trial_result · 2023-01-06Clinical Trial Update: Guide To Goals: A Novel Care Coordination Tool for Children With Type Two Diabetes (T2D)
A completed clinical trial evaluating a novel care coordination tool for children with type 2 diabetes; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: Olive Leaf Extracts in the Control of Cardiovascular Risk [Phase 2, Phase 3]
Phase 2 and Phase 3 trials evaluating olive leaf extracts for cardiovascular risk management in type 2 diabetes and hypertension.
-
CLINICAL_TRIALS trial_result · 2023-01-03Clinical Trial Update: Sitagliptin in Combination With Beidougen Capsule for Type 2 Diabetes [Phase 4]
Phase 4 trial update investigating sitagliptin in combination with Beidougen Capsule for type 2 diabetes.
-
FDA approval · 2022-12-21FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for BYETTA (exenatide) submitted by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics [Phase 2]
Phase 2 trial update for INS068 in patients with Type 2 diabetes inadequately controlled with one or two oral antidiabetics has completed.
-
CLINICAL_TRIALS research · 2022-12-21Clinical Trial Update: Evaluation of Accuracy of Continuous Glucose Monitoring (CGM) in Patients With End Stage Renal Disease (ESRD) on Intermittent Hemodialysis (iHD). [NA]
A completed clinical trial evaluating the accuracy of continuous glucose monitoring in patients with end-stage renal disease on intermittent…
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: Follow-up of NAFLD Patients With MRI-PDFF [Phase 4]
A Phase 4 follow-up trial evaluating NAFLD in patients with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes [Phase 2]
Phase 2 trial update evaluating GWP42004 as add-on therapy to metformin in type 2 diabetes completed.
-
CLINICAL_TRIALS trial_result · 2022-12-12Clinical Trial Update: HSK7653 Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial of HSK7653 as add-on to metformin in type 2 diabetes completed.
-
CLINICAL_TRIALS trial_result · 2022-12-12Clinical Trial Update: HSK7653 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise [Phase 3]
Phase 3 trial update for HSK7653 in adults with type 2 diabetes not adequately controlled by diet and exercise.
-
FDA approval · 2022-12-08FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk, resulting in labeling changes related to the pr…
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY [Phase 2]
Phase 2 trial update evaluating safety, tolerability, and pharmacodynamics of PF-06882961 in adults with type 2 diabetes mellitus and non-di…
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: Evaluating Use of Continuous Glucose Monitors in a Short-term 2x2-Crossover Study [NA]
Completed 2x2-crossover study evaluating use of continuous glucose monitors in type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2022-12-07Clinical Trial Update: Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes [Phase 4]
A Phase 4 trial investigating the role of canagliflozin on CD34+ cells in patients with type 2 diabetes; results have been posted.
-
FDA approval · 2022-11-30FDA Approved: APIDRA — Supplemental Application (sanofi-aventis U.S. LLC)
FDA approved a supplemental application for APIDRA (insulin glulisine) filed by Sanofi‑Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: Evaluation of Efficacy and Safety of Curalin As Add-On Therapy in Adults With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 clinical trial evaluating Curalin as add-on therapy for adults with type 2 diabetes to assess efficacy and safety.
-
CLINICAL_TRIALS withdrawal · 2022-11-29Clinical Trial Update: Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes [Phase 4]
A Phase 4 trial of vortioxetine monotherapy for major depressive disorder in patients with type 2 diabetes was withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes. [Phase 2]
A Phase 2 trial evaluating different doses of BI 456906 for adults with type 2 diabetes has completed with results posted.